Literature DB >> 12032477

Prediction of left ventricular wall motion recovery after acute myocardial infarction by Tl-201 gated SPECT: incremental value of integrated contractile reserve assessment.

Marcus Vinicius Simões1, Oswaldo César de Almeida-Filho, Antonio Osvaldo Pintya, Alexandre Baldini de Figueiredo, Cleide Marques Antloga, Fernando Vilela Salis, Nadia de Paula Batista, Moysés de Oliveira Lima-Filho, Benedito Carlos Maciel, José Antonio Marin-Neto.   

Abstract

BACKGROUND: This investigation tested the application of low-dose dobutamine (LDD) gated single photon emission computed tomography (SPECT) with thallium 201 for myocardial viability detection early after acute myocardial infarction (AMI). METHODS AND
RESULTS: Thirty-two hemodynamically stable post-AMI patients (aged 55 +/- 5 years [mean +/- SEM]; 20 men) who were exhibiting regional left ventricular dysfunction underwent stress-redistribution Tl-201 scanning within 4 to 8 days, followed by 2 additional gated SPECT acquisitions after Tl-201 reinjection, at rest and during LDD. A visual 5-point score was computed for segmental radiotracer uptake (0, normal; 4, absent) and a 4-point score for left ventricular wall motion (1, normal; 4, dyskinesis). Predominant viable myocardium in dyssynergic regions was predicted by a mean Tl-201 uptake score of 2 or less or ischemic area of 30% or greater. These indices showed a significant association with wall motion improvement in follow-up echocardiographic studies (overall accuracy = 0.69, sensitivity = 0.93, and specificity = 0.50). Regarding the response to LDD stimulus, an increase in mean wall motion score of 30% or greater was predictive of predominant viable myocardium. Contractile reserve assessment yielded a significant increment in the predictive accuracy for function recovery (overall accuracy = 0.84, sensitivity = 0.71, and specificity = 0.94).
CONCLUSIONS: Evaluation of contractile reserve by means of LDD gated SPECT with Tl-201 is safely feasible early after AMI, with incremental value over perfusion assessment alone for myocardial viability detection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032477     DOI: 10.1067/mnc.2002.120636

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  30 in total

1.  Low dose dobutamine echocardiography is more predictive of reversible dysfunction after acute myocardial infarction than resting single photon emission computed tomographic thallium-201 scintigraphy.

Authors:  S Smart; T Stoiber; R Hellman; J Duchak; J Wynsen; M Kitapci; A Isitman; A Krasnow; B D Collier; K Sagar
Journal:  Am Heart J       Date:  1997-11       Impact factor: 4.749

2.  Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery.

Authors:  P Marzullo; G Sambuceti; O Parodi; A Gimelli; E Picano; A Giorgetti; A L'Abbate
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

3.  Comparison of 201Tl scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability.

Authors:  G A Beller
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

4.  Evaluation of ventricular ejection fraction, wall motion, wall thickening, and other parameters with gated myocardial perfusion single-photon emission computed tomography.

Authors:  D S Berman; G Germano
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

5.  Quantification of left ventricular function with thallium-201 and technetium-99m-sestamibi myocardial gated SPECT.

Authors:  C Maunoury; C C Chen; K B Chua; C J Thompson
Journal:  J Nucl Med       Date:  1997-06       Impact factor: 10.057

Review 6.  Preservation of cardiac function by coronary thrombolysis during acute myocardial infarction: fact or myth?

Authors:  M S Verani; R Roberts
Journal:  J Am Coll Cardiol       Date:  1987-08       Impact factor: 24.094

7.  Assessment of regional and global left ventricular function by reinjection T1-201 and rest Tc-99m sestamibi ECG-gated SPECT: comparison with three-dimensional magnetic resonance imaging.

Authors:  E Tadamura; T Kudoh; M Motooka; M Inubushi; S Shirakawa; N Hattori; T Okada; T Matsuda; T Koshiji; K Nishimura; K Matsuda; J Konishi
Journal:  J Am Coll Cardiol       Date:  1999-03-15       Impact factor: 24.094

8.  Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction.

Authors:  D Kroll; W Farah; G R McKendall; S E Reinert; L L Johnson
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

9.  Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base.

Authors:  A Volpi; C De Vita; M G Franzosi; E Geraci; A P Maggioni; F Mauri; E Negri; E Santoro; L Tavazzi; G Tognoni
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

10.  201Tl and 99mTc-MIBI gated SPECT in patients with large perfusion defects and left ventricular dysfunction: comparison with equilibrium radionuclide angiography.

Authors:  A Manrique; M Faraggi; P Véra; D Vilain; R Lebtahi; A Cribier; D Le Guludec
Journal:  J Nucl Med       Date:  1999-05       Impact factor: 10.057

View more
  2 in total

1.  Rest and low-dose dobutamine Tc-99m-mibi gated-SPECT for early prediction of left ventricular remodeling after a first reperfused myocardial infarction.

Authors:  Laura Ernande; Florent Cachin; Pascal Chabrot; Nicolas Durel; Dominique Morand; Louis Boyer; Jean Maublant; Janusz Lipiecki
Journal:  J Nucl Cardiol       Date:  2009-05-29       Impact factor: 5.952

Review 2.  The expanding role of left ventricular functional assessment using gated myocardial perfusion SPECT: the supporting actor is stealing the scene.

Authors:  Roberto Sciagrà
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.